Printer Friendly

Articles from France Pharmaceutical (September 26, 2019)

1-9 out of 9 article(s)
Title Author Type Words
NicOx (COX). 1416
Pierre Fabre S.A. 336
Sanofi - CHMP recommends approval of Dupixent[R] (dupilumab) for severe chronic rhinosinusitis with nasal polyposis -- 20/9/2019. 325
Sanofi-Aventis (SNY). 721
SEPPIC. 120
Servier. 1670
Stallergenes, Inc. 779
The Industry. 506
Virbac. 1105

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters